GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Devonian Health Group GSD.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

6.75

+8.00%

Close of 5 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Devonian Health Group — daily TSXV:GSD Delayed
Market value
C$18.7m
Last close × shares
Volume
504
Shares, 5 Nov 2026

About Devonian Health Group

Its shares trade on TSX Venture under the ticker GSD.V. It has been listed since 9 September 2014. In the fiscal year to 31 July 2025, it reported revenue of C$23.6m and a net loss of C$6.0m. At that date it held total assets of C$15.8m and shareholders' equity of C$9.1m.

Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Montmagny, Quebec. The company went IPO on 2014-09-09. The firm's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. The company is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The firm's cosmeceutical products include R-Spinasome and Purgenesis.

Figures and description from our data supplier, not checked against the company's own report.

More about Devonian Health Group →

Latest on Devonian Health Group

Our reporting

We have not reported on Devonian Health Group yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Devonian Health Group's ticker?

Devonian Health Group trades as GSD.V on TSX Venture, under ISIN CA2518348834.

What was Devonian Health Group's last closing price?

6.75 on 5 Nov 2026. The figure is in CAD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.